
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.130 | 1.130 | 0.000 |
Stocks | 98.870 | 98.870 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.776 | 15.943 |
Price to Book | 1.666 | 1.880 |
Price to Sales | 1.712 | 1.468 |
Price to Cash Flow | 8.935 | 9.295 |
Dividend Yield | 3.059 | 3.031 |
5 Years Earnings Growth | 9.336 | 12.230 |
Name | Net % | Category Average |
---|---|---|
Industrials | 30.820 | 29.164 |
Healthcare | 28.900 | 27.299 |
Financial Services | 17.030 | 18.061 |
Basic Materials | 8.540 | 5.036 |
Consumer Defensive | 6.430 | 6.957 |
Consumer Cyclical | 5.270 | 6.310 |
Utilities | 3.010 | 3.917 |
Number of long holdings: 26
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
DSV | DK0060079531 | 14.31 | 1,238.5 | -1.51% | |
Novo Nordisk B | DK0062498333 | 10.15 | 423.0 | -0.63% | |
Danske Bank | DK0010274414 | 9.00 | 213.5 | -0.70% | |
Novozymes B | DK0060336014 | 8.44 | 409.9 | -0.02% | |
Coloplast | DK0060448595 | 6.76 | 702.0 | -0.03% | |
Vestas Wind | DK0061539921 | 5.96 | 88.3 | -2.54% | |
Pandora | DK0060252690 | 5.21 | 933.2 | -2.26% | |
Genmab | DK0010272202 | 5.18 | 1,285.5 | -0.58% | |
Carlsberg B | DK0010181759 | 4.93 | 890.0 | +2.89% | |
Tryg | DK0060636678 | 3.40 | 151.0 | -1.18% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LI Aktier Globale Indeks | 5.15B | -9.59 | 9.45 | 8.55 | ||
LI Aktier Globale III | 3.68M | 16.60 | 2.38 | - | ||
LI Aktier Globale II | 3.88M | -1.18 | 8.65 | 7.96 | ||
LI Aktier Globale | 5.22M | -0.68 | 7.76 | 9.16 | ||
LI Aktier Europa | 3.17M | 0.83 | 10.62 | 7.60 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review